Prestige Wealth Management Group’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19.6K | Hold |
236
| – | – | ﹤0.01% | 352 |
|
|
2025
Q1 | $19.1K | Hold |
236
| – | – | ﹤0.01% | 347 |
|
|
2024
Q4 | $21.3K | Hold |
236
| – | – | ﹤0.01% | 347 |
|
|
2024
Q3 | $23.3K | Hold |
236
| – | – | ﹤0.01% | 327 |
|
|
2024
Q2 | $21.9K | Hold |
236
| – | – | ﹤0.01% | 307 |
|
|
2024
Q1 | $22.4K | Hold |
236
| – | – | ﹤0.01% | 332 |
|
|
2023
Q4 | $21.1K | Hold |
236
| – | – | ﹤0.01% | 328 |
|
|
2023
Q3 | $17.2K | Hold |
236
| – | – | ﹤0.01% | 350 |
|
|
2023
Q2 | $19.6K | Hold |
236
| – | – | ﹤0.01% | 366 |
|
|
2023
Q1 | $18K | Hold |
236
| – | – | ﹤0.01% | 350 |
|
|
2022
Q4 | $19.6K | Hold |
236
| – | – | 0.01% | 355 |
|
|
2022
Q3 | $19K | Hold |
236
| – | – | 0.01% | 330 |
|
|
2022
Q2 | $18K | Sell |
236
-141
| -37% | -$10.8K | ﹤0.01% | 351 |
|
|
2022
Q1 | $34K | Hold |
377
| – | – | 0.01% | 276 |
|
|
2021
Q4 | $42K | Buy |
377
+124
| +49% | +$13.8K | 0.01% | 281 |
|
|
2021
Q3 | $32K | Hold |
253
| – | – | 0.01% | 303 |
|
|
2021
Q2 | $34K | Hold |
253
| – | – | 0.01% | 285 |
|
|
2021
Q1 | $34K | Buy |
253
+8
| +3% | +$1.08K | 0.01% | 288 |
|
|
2020
Q4 | $34K | Buy |
245
+9
| +4% | +$1.25K | 0.01% | 288 |
|
|
2020
Q3 | $26K | Hold |
236
| – | – | 0.01% | 320 |
|
|
2020
Q2 | $26K | Hold |
236
| – | – | 0.01% | 295 |
|
|
2020
Q1 | $18K | Hold |
236
| – | – | 0.01% | 301 |
|
|
2019
Q4 | $22K | Hold |
236
| – | – | 0.01% | 286 |
|
|
2019
Q3 | $18K | Hold |
236
| – | – | 0.01% | 295 |
|
|
2019
Q2 | $21K | Hold |
236
| – | – | 0.01% | 269 |
|
|
2019
Q1 | $21K | Hold |
236
| – | – | 0.01% | 276 |
|
|
2018
Q4 | $17K | Buy |
+236
| New | +$17K | 0.01% | 344 |
|